vs

Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and Evolus, Inc. (EOLS). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($90.3M vs $75.1M, roughly 1.2× SAUL CENTERS, INC.). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs 0.1%, a 8.5% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (14.4% vs 10.6%). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (23.4% CAGR vs 6.2%).

Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

BFS vs EOLS — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.2× larger
EOLS
$90.3M
$75.1M
BFS
Growing faster (revenue YoY)
EOLS
EOLS
+3.7% gap
EOLS
14.4%
10.6%
BFS
Higher net margin
BFS
BFS
8.5% more per $
BFS
8.7%
0.1%
EOLS
Faster 2-yr revenue CAGR
EOLS
EOLS
Annualised
EOLS
23.4%
6.2%
BFS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BFS
BFS
EOLS
EOLS
Revenue
$75.1M
$90.3M
Net Profit
$6.5M
$130.0K
Gross Margin
65.7%
Operating Margin
65.4%
4.7%
Net Margin
8.7%
0.1%
Revenue YoY
10.6%
14.4%
Net Profit YoY
-19.6%
101.9%
EPS (diluted)
$0.15
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFS
BFS
EOLS
EOLS
Q4 25
$75.1M
$90.3M
Q3 25
$72.0M
$69.0M
Q2 25
$70.8M
$69.4M
Q1 25
$71.9M
$68.5M
Q4 24
$67.9M
$78.9M
Q3 24
$67.3M
$61.1M
Q2 24
$66.9M
$66.9M
Q1 24
$66.7M
$59.3M
Net Profit
BFS
BFS
EOLS
EOLS
Q4 25
$6.5M
$130.0K
Q3 25
$10.5M
$-15.7M
Q2 25
$10.7M
$-17.1M
Q1 25
$9.8M
$-18.9M
Q4 24
$8.1M
$-6.8M
Q3 24
$14.5M
$-19.2M
Q2 24
$14.4M
$-11.3M
Q1 24
$13.6M
$-13.1M
Gross Margin
BFS
BFS
EOLS
EOLS
Q4 25
65.7%
Q3 25
66.5%
Q2 25
65.3%
Q1 25
68.1%
Q4 24
66.7%
Q3 24
73.6%
68.9%
Q2 24
74.2%
70.3%
Q1 24
72.8%
68.3%
Operating Margin
BFS
BFS
EOLS
EOLS
Q4 25
65.4%
4.7%
Q3 25
69.1%
-16.7%
Q2 25
68.7%
-14.7%
Q1 25
66.5%
-22.1%
Q4 24
82.9%
-2.9%
Q3 24
72.8%
-25.3%
Q2 24
75.0%
-11.5%
Q1 24
72.4%
-15.0%
Net Margin
BFS
BFS
EOLS
EOLS
Q4 25
8.7%
0.1%
Q3 25
14.6%
-22.8%
Q2 25
15.1%
-24.7%
Q1 25
13.6%
-27.6%
Q4 24
11.9%
-8.6%
Q3 24
21.5%
-31.4%
Q2 24
21.6%
-17.0%
Q1 24
20.4%
-22.1%
EPS (diluted)
BFS
BFS
EOLS
EOLS
Q4 25
$0.15
$0.01
Q3 25
$0.32
$-0.24
Q2 25
$0.33
$-0.27
Q1 25
$0.29
$-0.30
Q4 24
$0.22
$-0.11
Q3 24
$0.48
$-0.30
Q2 24
$0.48
$-0.18
Q1 24
$0.45
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFS
BFS
EOLS
EOLS
Cash + ST InvestmentsLiquidity on hand
$8.7M
$53.8M
Total DebtLower is stronger
$468.4M
$146.1M
Stockholders' EquityBook value
$307.8M
$-23.1M
Total Assets
$2.2B
$225.9M
Debt / EquityLower = less leverage
1.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFS
BFS
EOLS
EOLS
Q4 25
$8.7M
$53.8M
Q3 25
$11.8M
$43.5M
Q2 25
$5.3M
$61.7M
Q1 25
$6.5M
$67.9M
Q4 24
$10.3M
$87.0M
Q3 24
$7.2M
$85.0M
Q2 24
$6.9M
$93.7M
Q1 24
$7.1M
$97.0M
Total Debt
BFS
BFS
EOLS
EOLS
Q4 25
$468.4M
$146.1M
Q3 25
$1.6B
Q2 25
$1.6B
Q1 25
$1.5B
$121.8M
Q4 24
$455.8M
$121.5M
Q3 24
$1.5B
$121.2M
Q2 24
$1.4B
$120.9M
Q1 24
$1.4B
$120.6M
Stockholders' Equity
BFS
BFS
EOLS
EOLS
Q4 25
$307.8M
$-23.1M
Q3 25
$316.6M
$-28.8M
Q2 25
$322.4M
$-18.7M
Q1 25
$328.4M
$-6.6M
Q4 24
$335.8M
$5.5M
Q3 24
$341.8M
$5.9M
Q2 24
$345.7M
$19.3M
Q1 24
$347.1M
$18.4M
Total Assets
BFS
BFS
EOLS
EOLS
Q4 25
$2.2B
$225.9M
Q3 25
$2.2B
$219.0M
Q2 25
$2.1B
$228.8M
Q1 25
$2.1B
$213.4M
Q4 24
$2.1B
$232.6M
Q3 24
$2.1B
$229.6M
Q2 24
$2.1B
$233.8M
Q1 24
$2.0B
$226.2M
Debt / Equity
BFS
BFS
EOLS
EOLS
Q4 25
1.52×
Q3 25
5.02×
Q2 25
4.85×
Q1 25
4.70×
Q4 24
1.36×
22.00×
Q3 24
4.37×
20.58×
Q2 24
4.17×
6.26×
Q1 24
4.06×
6.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFS
BFS
EOLS
EOLS
Operating Cash FlowLast quarter
$99.8M
$12.8M
Free Cash FlowOCF − Capex
$11.3M
FCF MarginFCF / Revenue
12.6%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
15.35×
98.67×
TTM Free Cash FlowTrailing 4 quarters
$-45.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFS
BFS
EOLS
EOLS
Q4 25
$99.8M
$12.8M
Q3 25
$20.6M
$-14.7M
Q2 25
$26.6M
$-24.8M
Q1 25
$30.4M
$-15.6M
Q4 24
$121.2M
$4.8M
Q3 24
$26.5M
$-5.7M
Q2 24
$32.1M
$-6.5M
Q1 24
$33.8M
$-10.6M
Free Cash Flow
BFS
BFS
EOLS
EOLS
Q4 25
$11.3M
Q3 25
$-15.6M
Q2 25
$-25.5M
Q1 25
$-16.0M
Q4 24
$4.4M
Q3 24
$-28.3M
$-6.0M
Q2 24
$-12.5M
$-6.9M
Q1 24
$-11.7M
$-10.9M
FCF Margin
BFS
BFS
EOLS
EOLS
Q4 25
12.6%
Q3 25
-22.7%
Q2 25
-36.7%
Q1 25
-23.3%
Q4 24
5.5%
Q3 24
-42.1%
-9.9%
Q2 24
-18.7%
-10.4%
Q1 24
-17.6%
-18.3%
Capex Intensity
BFS
BFS
EOLS
EOLS
Q4 25
1.6%
Q3 25
1.4%
Q2 25
1.0%
Q1 25
0.5%
Q4 24
0.6%
Q3 24
81.5%
0.5%
Q2 24
66.7%
0.7%
Q1 24
68.3%
0.4%
Cash Conversion
BFS
BFS
EOLS
EOLS
Q4 25
15.35×
98.67×
Q3 25
1.97×
Q2 25
2.48×
Q1 25
3.10×
Q4 24
14.98×
Q3 24
1.83×
Q2 24
2.22×
Q1 24
2.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons